论文部分内容阅读
目的观察肌氨肽苷注射液联合1,6二磷酸果糖治疗小儿病毒性心肌炎的临床疗效。方法将74例病毒性心肌炎患儿随机分为治疗组和对照组,两组各37例,对照组采用常规治疗,治疗组在对照组治疗基础上加用肌氨肽苷注射液及1,6二磷酸果糖。14d为1疗程,观察两组患儿的临床症状、心电图、心肌酶谱等变化。结果治疗组临床疗效总有效率为94.6%,心电图总有率为97.3%,心急酶改善总有率为75.7%,治疗组疗效均优于对照组(P<0.05)。结论肌氨肽苷注射液联合1,6二磷酸果糖治疗小儿病毒性心肌炎临床效果显著,不良反映少,值得推广。
Objective To observe the clinical efficacy of muscle aminopeptidase injection combined with fructose-1,6 diphosphate in the treatment of viral myocarditis in children. Methods A total of 74 children with viral myocarditis were randomly divided into treatment group and control group, 37 cases in each group. The control group received routine treatment. The treatment group was treated with muscle aminopeptidase and 1,6 Fructose diphosphate. 14d for a course of treatment, observed in two groups of children’s clinical symptoms, ECG, myocardial enzymes and other changes. Results The total effective rate of the treatment group was 94.6%, the total electrocardiogram rate was 97.3%, and the rate of heart-ache enzyme improvement was 75.7%. The curative effect of the treatment group was better than that of the control group (P <0.05). Conclusion Muscle aminopeptidase injection combined fructose 1,6 diphosphate treatment of children with viral myocarditis significant clinical effect, less adverse reactions, it is worth promoting.